Labeled evans blue dye derivative for in vivo serum albumin labeling

US10258701B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10258701-B2
Application numberUS-201715587948-A
CountryUS
Kind codeB2
Filing dateMay 5, 2017
Priority dateMar 31, 2015
Publication dateApr 16, 2019
Grant dateApr 16, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed is a compound of formula (I): wherein L, R 1 -R 5 , A, B, M, and n are as defined in the specification, as well as a method of preparing the compound. Also disclosed are a method of blood-pool imaging in a mammal and a method of imaging a lymph node in a mammal, comprising use of the compound.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of imaging a lymph node in a mammal, consisting of administering to the mammal a compound of formula (I): Wherein M is selected from 18 F-AlF, 60 Cu, 61 Cu, 62 Cu, 64 Cu, 67 Cu, 68 Ga, 86 Y, 89 Zr, 111 In, 99m Tc, 186 Re, 188 Re, Gd 3+ , and Mn 2+ , and PET imaging the mammal, and optionally, coadministering to the mammal Evans blue dye, and visually imaging the mammal. 2. The method of claim 1 , wherein the compound of formula (I) is: 3. The method of claim 1 , wherein M is 18 F-AlF, 64 Cu, or 68 Ga. 4. The method of claim 3 , wherein the compound of formula (I) is: 5. The method of claim 1 , wherein the lymph node is a sentinel lymph node.

Assignees

Inventors

Classifications

  • Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium · CPC title

  • Amino naphtholsulfonic acid · CPC title

  • chelates from cyclic ligands, e.g. DOTA · CPC title

  • Complex metal compounds of azo dyes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10258701B2 cover?
Disclosed is a compound of formula (I): wherein L, R 1 -R 5 , A, B, M, and n are as defined in the specification, as well as a method of preparing the compound. Also disclosed are a method of blood-pool imaging in a mammal and a method of imaging a lymph node in a mammal, comprising use of the compound.
Who is the assignee on this patent?
Us Health
What technology area does this patent fall under?
Primary CPC classification A61K51/0482. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).